Delivery Order SPE2DB22D3004-SPE2DB24FPD84
Award Date
2/1/24
Potential Completion Date
2/2/24
Potential Value
$6.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order worth $1,250.40 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of 120 tablets of the pharmaceutical product CONTRAVE ER 8-90 MG. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00, which serves as the primary contract vehicle for AmerisourceBergen to deliver pharmaceutical products and medical supplies to DLA Troop...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of CONTRAVE ER 8-90 MG TABLET 120S. The contract has a potential value of $3,668.60 and a completion date of January 26, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period...
The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 120 tablets of the pharmaceutical product CONTRAVE ER 8-90 MG. The contract has a potential value of $2,040.68 and a completion date of February 15, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) with a potential value of up to $999,999,999.00, which serves...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of Contrave ER 8-90 mg tablets. The contract, valued at $1,814.81, has an ultimate completion date of April 2, 2024. AmerisourceBergen Drug Corp is the prime contractor and this award is associated with a $999,999,999.00 indefinite delivery contract (IDC) the company holds with DLA, which serves as the primary...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, to provide CONTRAVE ER 8-90 MG TABLET 120S. The order has a potential value of $7,315.15 and a completion date of February 6, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is not part of a set-aside program. Amerisourcebergen Drug Corp also holds an indefinite delivery contract (IDC) with DLA,...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Contrave ER 8-90 mg tablets. The contract has a ceiling value of $18,065.42 and a period of performance through April 12, 2024. This award is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 with a performance period through December 31, 2025, which serves as...
The U.S. Defense Logistics Agency (DLA) awarded a $5,563.06 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 120 tablets of the medication CONTRAVE ER 8-90 MG. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract...
The U.S. Defense Logistics Agency (DLA) awarded a $10,587.49 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of Contrave ER 8-90 mg tablets to support military treatment programs and facilities. The order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen Drug...
The U.S. Defense Logistics Agency (DLA) awarded a $3,606.02 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of the pharmaceutical product CONTRAVE ER 8-90 MG TABLET 120S. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the...
The Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,147,103 units of the prescription medication CONTRAVE ER 8-90 MG TABLET 120S. The $13,938.92 contract has an ultimate completion date of April 3, 2024 and is not designated as a set-aside. This delivery order is under an indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug...